SPAC (Special Purpose Acquisition Company) Transactions

SPAC (Special Purpose Acquisition Company) Transactions

An interdisciplinary practice advising the full range of market participants on complex transactions involving SPACs.

Key Contacts

Meet Our Team



    • Represented Jackson Acquisition Company, a SPAC led by Chairman of the Board of Directors Jeb Bush and President and CEO Richard L. Jackson, in its initial public offering with gross proceeds of $200 million.
    • Represented the underwriter in the $201 million SPAC IPO of Crescera Capital.
    • Currently representing other SPAC sponsors and underwriters in IPOs not yet publicly disclosed in the healthcare, life sciences and technology sectors; and advising companies and investment funds on going public strategies involving SPAC and dual and triple track processes (IPO/SPAC, and IPO/SPAC/traditional M&A).

    • Represented Altimeter Capital Management in Grab Holdings Inc.’s business combination with Altimeter Growth Corp., a SPAC, in a transaction valued at approximately $40 billion, the largest SPAC deal to date.
    • Represented Amplitude Healthcare Acquisition Corporation, a SPAC sponsored by affiliates of Avego Management, LLC and Metalmark Capital, in its business combination with Jasper Therapeutics.
    • Represented the private placement agents in a $60 million PIPE financing in connection with the business combination of eFFECTOR Therapeutics, Inc., a biopharmaceutical company focused on pioneering the development of selective translation regulation inhibitors (STRIS) for the treatment of cancer, with Locust Walk Acquisition Corp., a SPAC.
    • Represented investor in private placement in connection with business combination between Wag Labs, Inc. and CHW Acquisition Corporation.
    • Represented investor in connection with business combination between Circle Internet Financial and Concord Acquisition Corp.
    • Currently advising on other SPAC business combinations and the related financing arrangements such as PIPEs; representing investment fund and other clients in connection with investments in companies undertaking SPAC business combinations and in connection with continuing investments in de-SPAC’ed companies; advising de-SPAC’ed companies on securities law and disclosure matters; and representing management teams and minority stockholders in private equity controlled companies engaged in SPAC business combinations.
    • Other SPAC transactions in which we have been involved on behalf of our clients have included, among others, Thoma Bravo Advantage/ironSource, Longview Acquisition/Butterfly Network, Vesper Acquisition/Hydrafacial, Falcon Capital/Sharecare and HighCape/Quantum SI.

    • Advising SPAC participants on director responsibilities and other legal and liability considerations including enforcement risks; investment banks and other financial institutions on SPAC-related policies, including research analyst-related policies and derivatives-related policies; and monitoring regulatory, litigation and other developments relating to SPACs.

Insights & News


Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.